# FDA Inspection 1086635 - Apex Pharmaceuticals Inc. - April 18, 2019

Source: https://www.globalkeysolutions.net/records/fda_inspections/apex-pharmaceuticals-inc/acd2cd41-87e3-4b8f-ae9f-2ba918d9aa96
Source feed: FDA_Inspections

> FDA Inspection 1086635 for Apex Pharmaceuticals Inc. on April 18, 2019. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1086635
- Company Name: Apex Pharmaceuticals Inc.
- Inspection Date: 2019-04-18
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.globalkeysolutions.net/companies/apex-pharmaceuticals-inc/6e156f16-7c9b-40b7-a267-0c315ab67b38

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c